NFKB1 and metabolic dysfunction-associated steatohepatitis: For example, severe NASH, cirrhosis and liver cancer have been reported to occur in non-obese mice with targeted genetic defects that enhance insulin sensitivity [45], or that disrupt signaling that activates NF-kB (a major pro-inflammatory factor) [46].